Started Wegovy and still feeling hungry? Here's what's normal

The misconception worth clearing up first: Wegovy does not switch hunger off from day one

A question our prescribers hear most weeks is some version of: "I started my injections two weeks ago and I'm still eating the same amount, is something wrong?" Almost always, the answer is no. The expectation that semaglutide produces immediate, dramatic appetite suppression is one of the most persistent misunderstandings about this treatment.

Wegovy's licensed titration schedule begins at 0.25mg, a dose designed to let your body adjust rather than to deliver the full therapeutic effect. The maintenance dose is 2.4mg (eight times higher) and that escalation happens over roughly five months of gradual 4-weekly steps. Clinical trial data published in the STEP 1 study in the New England Journal of Medicine found an average weight reduction of around 15% over 68 weeks: that figure reflects the full titration period, not the first fortnight. Expecting the final result at the first dose is like expecting to hear music clearly when the volume is on its lowest setting.

The NHS medicines page for semaglutide notes that effects on appetite develop as treatment progresses, which is exactly why the programme runs over months rather than weeks. Give it time. The early weeks are the adjustment phase, not the verdict.

Physical hunger versus habit: two different things the medicine does not treat equally

Once hunger does begin to quieten, patients often notice something unexpected: they still reach for food at their usual times, or when stressed, or in front of the television. This is not a sign that Wegovy has stopped working. It points to the difference between physiological hunger (the biological drive regulated by GLP-1 receptors) and habitual or emotional eating, which is driven by learned behaviour, routine and mood.

Semaglutide addresses the first category directly. The second requires conscious attention alongside treatment. What you eat on Wegovy matters partly for this reason: structured meals with adequate protein and fibre give your body a clear signal that it has genuinely eaten, which can help close the gap between what the medicine quietens and what habit still prompts.

If emotional or habitual eating feels like the dominant challenge, it is worth raising with your prescriber. Some people find keeping a brief food-and-feeling log for a week or two helps them spot patterns. The medicine is a tool; understanding which type of hunger you're managing on any given day makes that tool more effective.

What tends to make hunger worse in the early weeks

Certain choices can actively undermine the appetite control Wegovy is starting to build. Ultra-processed foods and drinks high in refined sugar tend to produce short-lived fullness followed by sharp hunger signals, the opposite of what the treatment is working toward. Meals too low in protein lead to faster stomach emptying and earlier return of hunger, even with semaglutide on board.

Eating too quickly is another factor. Because Wegovy slows gastric emptying, fullness signals arrive later than they did before treatment, eating at speed means it's easy to overshoot. Smaller portions, slower pacing and pausing mid-meal can make a practical difference.

Hydration also plays a role. Thirst and mild hunger are often confused, and early in treatment when the appetite signal is still developing, a glass of water before a meal can help clarify whether the sensation is genuine hunger. The NHS Live Well healthy weight guidance covers these dietary basics in plain terms and is a useful read alongside treatment. For more on navigating hunger at a specific dose, hunger at 5mg has further detail on what many people experience as titration progresses.

When to talk to your prescriber about persistent hunger

Hunger that simply has not settled is different from hunger that was improving and has returned. The latter can sometimes indicate that a dose increase is due, or that something in your routine has shifted. Neither situation calls for alarm, but both are worth mentioning rather than managing alone.

If you're finding that appetite control is minimal even after several weeks at a given dose, your prescriber can review whether the titration schedule is progressing appropriately, whether there are any interactions affecting the medicine, and whether there are specific strategies worth trying. This is precisely what aftercare is for. You can read more about persistent hunger on Wegovy and how it tends to resolve, or explore why hunger sometimes persists even after several injections.

For a broader picture of how semaglutide works and what the full treatment programme involves, the Wegovy overview page covers the licensed indication, the titration schedule and what clinical evidence shows. If you're considering starting treatment or want to talk through whether Wegovy is the right option, the team at our treatment consultation page is the right starting point, every consultation is reviewed by a named, GPhC-registered prescriber the same day. Information on Wegovy pricing is also available if cost is part of your decision.